Thymectomy in myasthenia gravis: when, why, and how?

Volume: 18, Issue: 3, Pages: 225 - 226
Published: Mar 1, 2019
Abstract
Myasthenia gravis is an autoimmune disease mediated by antibodies against proteins expressed in the neuromuscular junction; the main antigen is the acetylcholine receptor. In patients with myasthenia gravis, the thymus can have histological abnormalities, such as follicular hyperplasia or thymoma. Although thymectomy is standard treatment for patients with myasthenia gravis who have thymoma, whether the procedure is of any clinical benefit in...
Paper Details
Title
Thymectomy in myasthenia gravis: when, why, and how?
Published Date
Mar 1, 2019
Volume
18
Issue
3
Pages
225 - 226
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.